Microbix Biosystems Inc (MBX.TO)
0.33
-0.02
(-5.71%)
CAD |
TSX |
May 17, 14:46
Microbix Biosystems Revenue (Quarterly): 8.408M for Dec. 31, 2023
Revenue (Quarterly) Chart
Historical Revenue (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 8.408M |
| September 30, 2023 | 4.264M |
| June 30, 2023 | 5.530M |
| March 31, 2023 | 4.218M |
| December 31, 2022 | 2.502M |
| September 30, 2022 | 4.329M |
| June 30, 2022 | 5.011M |
| March 31, 2022 | 4.881M |
| December 31, 2021 | 4.856M |
| September 30, 2021 | 5.630M |
| June 30, 2021 | 5.452M |
| March 31, 2021 | 4.354M |
| December 31, 2020 | 3.158M |
| September 30, 2020 | 2.706M |
| June 30, 2020 | 2.898M |
| March 31, 2020 | 2.874M |
| December 31, 2019 | 2.046M |
| September 30, 2019 | 3.587M |
| June 30, 2019 | 3.111M |
| March 31, 2019 | 4.254M |
| December 31, 2018 | 2.461M |
| September 30, 2018 | 3.390M |
| June 30, 2018 | 3.235M |
| March 31, 2018 | 3.000M |
| December 31, 2017 | 2.886M |
| Date | Value |
|---|---|
| September 30, 2017 | 2.813M |
| June 30, 2017 | 2.773M |
| March 31, 2017 | 2.647M |
| December 31, 2016 | 1.952M |
| September 30, 2016 | 3.471M |
| June 30, 2016 | 2.253M |
| March 31, 2016 | 2.730M |
| December 31, 2015 | 1.063M |
| September 30, 2015 | 2.114M |
| June 30, 2015 | 2.219M |
| March 31, 2015 | 2.545M |
| December 31, 2014 | 1.996M |
| September 30, 2014 | 2.356M |
| June 30, 2014 | 2.040M |
| March 31, 2014 | 2.073M |
| December 31, 2013 | 1.928M |
| September 30, 2013 | 2.469M |
| June 30, 2013 | 1.907M |
| March 31, 2013 | 2.103M |
| December 31, 2012 | 0.9044M |
| September 30, 2012 | 1.885M |
| June 30, 2012 | 1.414M |
| March 31, 2012 | 1.897M |
| December 31, 2011 | 1.474M |
| September 30, 2011 | 2.138M |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (Quarterly) Range, Past 5 Years
2.046M
Minimum
Dec 2019
8.408M
Maximum
Dec 2023
4.201M
Average
4.264M
Median
Sep 2023
Revenue (Quarterly) Benchmarks
| Biocure Technology Inc | -- |
| Core One Labs Inc | 0.0937M |
| Nova Mentis Life Science Corp | 0.0283M |
| Nanosphere Health Sciences Inc | -- |
| Lobe Sciences Ltd | -- |
Revenue (Quarterly) Related Metrics
| Net Income (Quarterly) | 2.455M |
| Total Expenses (Quarterly) | 5.838M |
| EPS Diluted (Quarterly) | 0.018 |
| Enterprise Value | 40.87M |
| Gross Profit Margin (Quarterly) | 74.01% |
| Profit Margin (Quarterly) | 29.20% |
| Earnings Yield | 8.16% |
| Operating Earnings Yield | 2.25% |
| Normalized Earnings Yield | 8.161 |